AMFPF
Price
$27.60
Change
-$0.00 (-0.00%)
Updated
Feb 12 closing price
Capitalization
8.23B
NSVGF
Price
$0.01
Change
-$0.01 (-50.00%)
Updated
Nov 13 closing price
Capitalization
4.72M
Ad is loading...

AMFPF vs NSVGF

Header iconAMFPF vs NSVGF Comparison
Open Charts AMFPF vs NSVGFBanner chart's image
Amplifon S.p.A
Price$27.60
Change-$0.00 (-0.00%)
Volume$1.08K
Capitalization8.23B
Nass Vy Gateway
Price$0.01
Change-$0.01 (-50.00%)
Volume$29.75K
Capitalization4.72M
AMFPF vs NSVGF Comparison Chart
Loading...
View a ticker or compare two or three
VS
AMFPF vs. NSVGF commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMFPF is a Hold and NSVGF is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (AMFPF: $27.60 vs. NSVGF: $0.01)
Brand notoriety: AMFPF and NSVGF are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: AMFPF: 102% vs. NSVGF: 100%
Market capitalization -- AMFPF: $8.23B vs. NSVGF: $4.72M
AMFPF [@Medical Distributors] is valued at $8.23B. NSVGF’s [@Medical Distributors] market capitalization is $4.72M. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $9.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMFPF’s FA Score shows that 0 FA rating(s) are green whileNSVGF’s FA Score has 0 green FA rating(s).

  • AMFPF’s FA Score: 0 green, 5 red.
  • NSVGF’s FA Score: 0 green, 5 red.
According to our system of comparison, AMFPF is a better buy in the long-term than NSVGF.

Price Growth

AMFPF (@Medical Distributors) experienced а 0.00% price change this week, while NSVGF (@Medical Distributors) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was -0.23%. For the same industry, the average monthly price growth was -0.54%, and the average quarterly price growth was +1.96%.

Industries' Descriptions

@Medical Distributors (-0.23% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

FUNDAMENTALS
Fundamentals
AMFPF($8.23B) has a higher market cap than NSVGF($4.72M). AMFPF YTD gains are higher at: 6.144 vs. NSVGF (0.000). AMFPF has higher annual earnings (EBITDA): 520M vs. NSVGF (-1.57M). AMFPF has more cash in the bank: 198M vs. NSVGF (0). NSVGF has less debt than AMFPF: NSVGF (1.24M) vs AMFPF (1.58B). AMFPF has higher revenues than NSVGF: AMFPF (2.22B) vs NSVGF (29.5K).
AMFPFNSVGFAMFPF / NSVGF
Capitalization8.23B4.72M174,386%
EBITDA520M-1.57M-33,178%
Gain YTD6.1440.000-
P/E Ratio40.21N/A-
Revenue2.22B29.5K7,538,983%
Total Cash198M0-
Total Debt1.58B1.24M127,508%
FUNDAMENTALS RATINGS
AMFPF: Fundamental Ratings
AMFPF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
PROFIT vs RISK RATING
1..100
88
SMR RATING
1..100
57
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
47
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SEGIX39.62-0.58
-1.44%
NAA Large Cap Value C
AUUIX22.42-0.33
-1.45%
AB Select US Equity I
JDMRX126.74-2.01
-1.56%
Janus Henderson Enterprise R
IYIGX35.62-0.69
-1.90%
Macquarie Global Growth Fund Class R
ARAIX72.03-1.55
-2.11%
Ariel Fund Institutional

AMFPF and

Correlation & Price change

A.I.dvisor tells us that AMFPF and ZYXI have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMFPF and ZYXI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMFPF
1D Price
Change %
AMFPF100%
N/A
ZYXI - AMFPF
10%
Poorly correlated
-2.97%
COSM - AMFPF
2%
Poorly correlated
-1.89%
NSVGF - AMFPF
1%
Poorly correlated
N/A
SHPMY - AMFPF
0%
Poorly correlated
+3.75%
MAHLY - AMFPF
0%
Poorly correlated
N/A
More

NSVGF and

Correlation & Price change

A.I.dvisor tells us that NSVGF and SHPMY have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NSVGF and SHPMY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NSVGF
1D Price
Change %
NSVGF100%
N/A
SHPMY - NSVGF
14%
Poorly correlated
+3.75%
ZYXI - NSVGF
8%
Poorly correlated
-2.97%
PDRX - NSVGF
8%
Poorly correlated
N/A
SHTDF - NSVGF
4%
Poorly correlated
N/A
AMFPF - NSVGF
1%
Poorly correlated
N/A
More